Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Dec 2021 for Viveve Medical, INC., €2.
Filing timeline
BuySaleScott Durbin
Insider track record
Disclosed buys
9
Disclosed sells
1
Signal history
Closed purchases
Market purchases
9
Positive at T+90
57%
Median T+90
+28.0%
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -43.9%Entry US$5,510.00 · Close at T+365 US$3,090.00
- -31.7%Entry US$52.40 · Close at T+365 US$35.80
- -5.2%Entry US$46.40 · Close at T+365 US$44.00
- +79.3%Entry US$29.00 · Close at T+365 US$52.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Scott Durbin: trading record in brief
Scott Durbin (chief executive) discloses dealings in 2 companies, chiefly Vericel Corp and Viveve Medical, Inc. Over a trading history stretching from 26 August 2010 to 15 December 2021, the count stands at 12 filings.
Both buying and selling appear: 9 purchases worth €99k, against 1 sale worth €55k. Purchases outweigh sales by €44k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
Half of the purchases are above €13k and half below. Ninety days after publication, 7 purchases show a median change of +28.0%, with the price up in 57% of them. Past outcomes like these are no guarantee of what comes next.
Most recently, on 17 December 2021, the filings show a transaction worth €2 in Viveve Medical, Inc. The clock since the last published purchase (23 August 2017) now reads 3,352 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Scott Durbin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
2 shares@ US$1.40100.0% of flowCommon StockSEC:0001437749-21-028890:0
62,250 shares0Common StockSEC:0001437749-19-002144:0
5,000 shares@ US$5.2564.1% of flowCommon StockSEC:0001437749-17-015218:0
Canonical exit: 21 Nov 2017 (T+90)
1,500 shares@ US$5.00Common StockSEC:0001437749-16-034194:0
Canonical exit: 15 Sept 2016 (T+90)
40,541 shares@ US$0.37Common StockSEC:0001437749-15-010056:0
Canonical exit: 10 Aug 2015 (T+90)
40,000 shares@ US$1.80Common StockSEC:0001179110-12-000568:0
850 shares@ US$2.18Common StockSEC:0001179110-11-012158:0
Canonical exit: 8 Nov 2011 (T+90)
10,000 shares@ US$2.24Common StockSEC:0001179110-11-012158:1
Canonical exit: 9 Nov 2011 (T+90)
13,537 shares@ US$2.17Common StockSEC:0001209191-11-016248:0
Canonical exit: 2 Jun 2011 (T+90)
200 shares@ US$1.43Common StockSEC:0001209191-10-044197:0
Canonical exit: 24 Nov 2010 (T+90)
2,513 shares@ US$1.44Common StockSEC:0001209191-10-044197:1
Canonical exit: 24 Nov 2010 (T+90)
13,750 shares@ US$1.45Common StockSEC:0001209191-10-044197:2
Canonical exit: 24 Nov 2010 (T+90)
12 of 12 declarations
